Medidata is a company developing solutions for clinical development, commercial, and real-world data. It offers Medidata Rave Clinical Cloud, a platform that optimizes operational execution, decreases the data entry and maintenance burden, and reduce the number of clinical systems across study teams. The platform helps pharmaceutical, biotech, medical device companies, and academic researchers accelerate value, minimize risk, and optimize outcomes.

Employee Rating

4.2More
TypeSubsidiary
Parent CompanyDassault Systemes
HQNew York, US
Founded1999
Websitemedidata.com
Medidata was founded in 1999 and is headquartered in New York, US

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Medidata

Tarek Sherif

Tarek Sherif

Co-Founder, Co-CEO
Glen de Vries

Glen de Vries

Co-Founder, Co-CEO
Rouven Bergmann

Rouven Bergmann

EVP, COO, CFO
Arnaub Chatterjee

Arnaub Chatterjee

Senior Vice President - Product and Ecosystem, Acorn AI
Christian Hebenstreit

Christian Hebenstreit

SVP, EMEA Region
Fareed Melhem

Fareed Melhem

SVP, Acorn AI Labs
Show more

Medidata Office Locations

Medidata has offices in New York, Boston, Cincinnati, Davis and in 9 other locations
New York, US (HQ)
350 Hudson St
Boston, US
110 High St
Cincinnati, US
600 Vine St #2010
Davis, US
105 E St #2BDavis
Houston, US
1301 Fannin St
San Francisco, US
343 Sansome St, San Francisco
Show all (16)

Medidata Financials and Metrics

Summary Metrics

Founding Date

1999

Total Funding

$20 m

Investors

Medidata is a subsidiary of Dassault Systemes

Medidata Revenue

Embed Graph
View revenue for all periods
Medidata's revenue was reported to be $635.70 m in FY, 2018 which is a 16.5% increase from the previous period.
Annual
USDFY, 2016FY, 2017FY, 2018

Revenue

463.4m545.5m635.7m

Revenue growth, %

18%18%17%

Cost of goods sold

112.6m126.8m159.2m

Gross profit

350.8m418.7m476.5m
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

126.8m137.4m140.1m149.2m155.9m163.4m173.5m180.5m

Cost of goods sold

30.6m31.9m31.6m36.3m37.5m42.2m46.0m49.6m

Gross profit

96.2m105.5m108.5m112.9m118.4m121.2m127.5m130.9m

Gross profit Margin, %

76%77%77%76%76%74%73%73%
Annual
USDFY, 2016FY, 2017FY, 2018

Cash

93.5m237.3m105.4m

Accounts Receivable

128.5m110.7m170.7m

Prepaid Expenses

20.4m37.3m28.9m

Current Assets

518.8m637.6m462.5m
Quarterly
Annual
USDFY, 2016FY, 2017FY, 2018

Net Income

29.0m44.4m51.9m

Depreciation and Amortization

15.3m24.1m35.0m

Accounts Payable

2.8m(3.0m)3.5m

Cash From Operating Activities

88.8m121.7m89.2m
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Net Income

9.5m17.8m30.6m10.3m26.9m37.6m11.1m19.0m

Depreciation and Amortization

4.5m10.1m16.9m7.8m16.2m25.3m10.5m22.2m

Accounts Payable

130.0k4.5m(3.8m)2.6m1.8m3.5m1.4m1.2m

Cash From Operating Activities

22.5m60.7m91.6m5.0m23.8m57.2m6.1m30.4m
Show all financial metrics

Medidata Operating Metrics

FY, 2016FY, 2017FY, 2018

Backlog (Multi-Year Subscription)

$745 m$1.04 b$1.17 b

Countries (Customers)

30

Countries (Offices)

7

Enterprise Customers

849 1 k
Show all operating metrics

Medidata Acquisitions / Subsidiaries

Company NameDateDeal Size
SHYFT AnalyticsJune 12, 2018
MutrusApril 17, 2017
CHITA Inc.February 01, 2017
Intelemage, LLCApril 04, 2016
Clinical ForceJune 20, 2011
Fast TrackMarch 17, 2008
MDSOL Europe Limited
Medidata Consent Services, LLC
Medidata Europe Data Services, LLC
Medidata Holdings, Inc.
Show more

Medidata Revenue Breakdown

Embed Graph

Medidata revenue breakdown by business segment: 84.3% from Subscription and 15.7% from Professional Services

Medidata revenue breakdown by geographic segment: 14.1% from Europe, Middle East and Africa, 6.0% from Japan, 74.9% from United States and 5.0% from Other

Medidata Online and Social Media Presence

Embed Graph

Medidata News and Updates

Dow Jones Newswires: Dassault Systemes gets U.S. clearance for Medidata buy as it sets new targets

The French software maker said the CFIUS clearance was one of the final conditions for the merger, which should be completed in the coming days.

Dassault Systèmes announces extension of CFIUS review process for planned acquisition of Medidata

Dassault Systèmes announces extension of CFIUS review process for planned acquisition of Medidata

Medidata acquired by Dassault Systèmes for $5.8 billion

Medidata’s cloud-based services help with the development of therapeutic innovations and clinical operations performance for pharmaceutical companies, biotechnology firms and others.

Dassault Systemes buys clinical trials software provider Medidata for $5.8B

French technology giant Dassault Systemes SE says its agreed a deal to acquire U.S. life sciences firm Medidata Solutions Inc. in an all-cash deal valued at $5.8 billion. The company said it wants to expand its presence in a life sciences market that was worth $8.2 billion in 2016 and is expected t…

Dassault Dives into Health Tech, Buying Medidata for $5.7 Billion

“This is by far the largest acquisition we’ve ever made,” Dassault's CFO said on a conference call.
Show more

Medidata Blogs

Delegating Power to Patients in the Clinical Research Process

This post is guest-authored by Christian Hebenstreit, General Manager and Senior Vice President, EMEA, Medidata. In recent years, patient engagement in clinical trials has emerged as an increasingly important aspect of their delivery. This is because across all involved groups — sponsors, academics,…

Meet a Medidatian: Carol G., Director, The Academy, and lover of the Arts!

March is Women’s History Month. Medidata is proud to celebrate the social, economic, cultural and political achievements of women. On March 8th, International Women’s Day marked a call to action for accelerating women’s equality. This month, female Medidatians (that’s what we call Medidata employees…

Five Ways to Manage Your Trial Effectively in a Fast-Changing Global Environment

Over the past half-century, clinical trials have grown increasingly complex. A flood of new data from novel sources combined with more elaborate study designs and tougher regulatory standards have lengthened timelines and hiked costs, contributing to a steady decline of efficiency. It all adds up: N…

Meet Our Medidatian Women

March is Women’s History Month. Medidata is proud to celebrate the social, economic, cultural and political achievements of women. March 8th marked International Women’s Day, a call to action for accelerating women’s equality. This month, female Medidatians (that’s what we call Medidata employees) f…

The Challenges of Advancing Rare Disease Trials

There are about 7,000 rare diseases affecting over 400 million people worldwide with more discovered every year. Yet, only 500 therapies have been approved.1 Since the 1993 Orphan Drug Act, the number of rare disease designations has skyrocketed. With global sales forecasted to reach $262 billion by…

Rare Diseases Are a Common Pursuit at Medidata

It’s well established that Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Most of us think of the millions of people coping with heart disease or cancer or diabetes. But there are thousands of illnesses, rare diseases – sometimes called orpha…
Show more

Medidata Frequently Asked Questions

  • When was Medidata founded?

    Medidata was founded in 1999.

  • Who are Medidata key executives?

    Medidata's key executives are Tarek Sherif, Glen de Vries and Rouven Bergmann.

  • What is Medidata revenue?

    Latest Medidata annual revenue is $635.7 m.

  • Who are Medidata competitors?

    Competitors of Medidata include M-Files, Capsule Technologies and Health Catalyst.

  • Where is Medidata headquarters?

    Medidata headquarters is located at 350 Hudson St, New York.

  • Where are Medidata offices?

    Medidata has offices in New York, Boston, Cincinnati, Davis and in 9 other locations.

  • How many offices does Medidata have?

    Medidata has 16 offices.